Eucrates Biomedical
Why Robinhood?
You can watch EUCR and buy or sell other stocks, ETFs, and their options commission-free!About EUCR
Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY.
EUCR Key Statistics
Stock Snapshot
With a market cap of 42.23M, Eucrates Biomedical(EUCR) trades at $10.04. The stock has a price-to-earnings ratio of 53.46.
During the trading day, Eucrates Biomedical(EUCR) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Eucrates Biomedical(EUCR) stock has reached 0, versus its average volume of 7.18K.
The stock's 52-week range extends from a low of $9.87 to a high of $10.25.
The stock's 52-week range extends from a low of $9.87 to a high of $10.25.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.